搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Ralstonia solanacearum UPF0324 membrane protein RSc1111 (RSc1111), partial CSB-YP820402RAR
CSB-EP820402RAR
CSB-BP820402RAR
CSB-MP820402RAR
CSB-EP820402RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Acyl carrier protein 1 (acpP1) CSB-YP820403RAR
CSB-EP820403RAR
CSB-BP820403RAR
CSB-MP820403RAR
CSB-EP820403RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Putative NADH dehydrogenase/NAD (P)H nitroreductase RSc1004 (RSc1004) CSB-YP820404RAR
CSB-EP820404RAR
CSB-BP820404RAR
CSB-MP820404RAR
CSB-EP820404RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum 50S ribosomal protein L19 (rplS) CSB-YP820405RAR
CSB-EP820405RAR
CSB-BP820405RAR
CSB-MP820405RAR
CSB-EP820405RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum ADP-L-glycero-D-manno-heptose-6-epimerase (hldD) CSB-YP820406RAR
CSB-EP820406RAR
CSB-BP820406RAR
CSB-MP820406RAR
CSB-EP820406RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Bacteriohemerythrin (RSc0777) CSB-YP820407RAR
CSB-EP820407RAR
CSB-BP820407RAR
CSB-MP820407RAR
CSB-EP820407RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Serine hydroxymethyltransferase 1 (glyA1) CSB-YP820408RAR
CSB-EP820408RAR
CSB-BP820408RAR
CSB-MP820408RAR
CSB-EP820408RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Bis (5'-nucleosyl)-tetraphosphatase, symmetrical (apaH) CSB-YP820409RAR
CSB-EP820409RAR
CSB-BP820409RAR
CSB-MP820409RAR
CSB-EP820409RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum 60 kDa chaperonin (groL), partial CSB-YP820410RAR
CSB-EP820410RAR
CSB-BP820410RAR
CSB-MP820410RAR
CSB-EP820410RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Succinyl-CoA ligase [ADP-forming] subunit beta (sucC) CSB-YP820411RAR
CSB-EP820411RAR
CSB-BP820411RAR
CSB-MP820411RAR
CSB-EP820411RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Putative fis-like DNA-binding protein (RSc0505) CSB-YP820412RAR
CSB-EP820412RAR
CSB-BP820412RAR
CSB-MP820412RAR
CSB-EP820412RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum D-tyrosyl-tRNA (Tyr) deacylase (dtd) CSB-YP820413RAR
CSB-EP820413RAR
CSB-BP820413RAR
CSB-MP820413RAR
CSB-EP820413RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Probable ubiquinone biosynthesis protein UbiB (ubiB), partial CSB-YP820414RAR1
CSB-EP820414RAR1
CSB-BP820414RAR1
CSB-MP820414RAR1
CSB-EP820414RAR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Formamidopyrimidine-DNA glycosylase (mutM) CSB-YP820415RAR
CSB-EP820415RAR
CSB-BP820415RAR
CSB-MP820415RAR
CSB-EP820415RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Protoheme IX farnesyltransferase (ctaB), partial CSB-YP820416RAR
CSB-EP820416RAR
CSB-BP820416RAR
CSB-MP820416RAR
CSB-EP820416RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Arginine--tRNA ligase (argS), partial CSB-YP820417RAR
CSB-EP820417RAR
CSB-BP820417RAR
CSB-MP820417RAR
CSB-EP820417RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Diaminopimelate epimerase (dapF) CSB-YP820418RAR
CSB-EP820418RAR
CSB-BP820418RAR
CSB-MP820418RAR
CSB-EP820418RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Glutamyl-tRNA (Gln) amidotransferase subunit C (gatC) CSB-YP820419RAR
CSB-EP820419RAR
CSB-BP820419RAR
CSB-MP820419RAR
CSB-EP820419RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ralstonia solanacearum Homoserine O-acetyltransferase (metX) CSB-YP820420RAR
CSB-EP820420RAR
CSB-BP820420RAR
CSB-MP820420RAR
CSB-EP820420RAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Listeria monocytogenes serovar 1/2a Rhamnulokinase (rhaB) CSB-YP820421LPY
CSB-EP820421LPY
CSB-BP820421LPY
CSB-MP820421LPY
CSB-EP820421LPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>